Heparin Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Heparin Market, By Type

7.1.  Heparin Market, By Type, 2020-2028

7.1.1.    Low Molecular Weight Heparin

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Ultra-low Molecular Weight Heparin

7.1.2.1.        Market Revenue and Forecast (2016-2028)

7.1.3.    Unfractionated Heparin

7.1.3.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Heparin Market, By Application

8.1.  Heparin Market, by Application, 2020-2028

8.1.1.    Venous Thromboembolism

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Atrial Fibrillation

8.1.2.1.        Market Revenue and Forecast (2016-2028)

8.1.3.    Renal Impairment

8.1.3.1.        Market Revenue and Forecast (2016-2028)

8.1.4.    Coronary Artery Disease

8.1.4.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Heparin Market, By End User

9.1.  Heparin Market, by End User, 2020-2028

9.1.1.    Outpatient

9.1.1.1.        Market Revenue and Forecast (2016-2028)

9.1.2.    Inpatient

9.1.2.1.        Market Revenue and Forecast (2016-2028)

Chapter 10.      Global Heparin Market, By Route of Administration

10.1.        Heparin Market, By Route of Administration, 2020-2028

10.1.1.  Intravenous

10.1.1.1.      Market Revenue and Forecast (2016-2028)

10.1.2.  Subcutaneous

10.1.2.1.      Market Revenue and Forecast (2016-2028)

Chapter 11.      Global Heparin Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, By Type (2016-2028)

11.1.2.  Market Revenue and Forecast, by Application (2016-2028)

11.1.3.  Market Revenue and Forecast, by End User (2016-2028)

11.1.4.  Market Revenue and Forecast, By Route of Administration (2016-2028)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, By Type (2016-2028)

11.1.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.1.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.1.5.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, By Type (2016-2028)

11.1.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.1.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.1.6.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, By Type (2016-2028)

11.2.2.  Market Revenue and Forecast, by Application (2016-2028)

11.2.3.  Market Revenue and Forecast, by End User (2016-2028)

11.2.4.  Market Revenue and Forecast, By Route of Administration (2016-2028)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, By Type (2016-2028)

11.2.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.2.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.2.5.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, By Type (2016-2028)

11.2.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.2.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.2.6.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, By Type (2016-2028)

11.2.7.2.      Market Revenue and Forecast, by Application (2016-2028)

11.2.7.3.      Market Revenue and Forecast, by End User (2016-2028)

11.2.7.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, By Type (2016-2028)

11.2.8.2.      Market Revenue and Forecast, by Application (2016-2028)

11.2.8.3.      Market Revenue and Forecast, by End User (2016-2028)

11.2.8.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, By Type (2016-2028)

11.3.2.  Market Revenue and Forecast, by Application (2016-2028)

11.3.3.  Market Revenue and Forecast, by End User (2016-2028)

11.3.4.  Market Revenue and Forecast, By Route of Administration (2016-2028)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, By Type (2016-2028)

11.3.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.3.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.3.5.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, By Type (2016-2028)

11.3.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.3.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.3.6.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, By Type (2016-2028)

11.3.7.2.      Market Revenue and Forecast, by Application (2016-2028)

11.3.7.3.      Market Revenue and Forecast, by End User (2016-2028)

11.3.7.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, By Type (2016-2028)

11.3.8.2.      Market Revenue and Forecast, by Application (2016-2028)

11.3.8.3.      Market Revenue and Forecast, by End User (2016-2028)

11.3.8.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, By Type (2016-2028)

11.4.2.  Market Revenue and Forecast, by Application (2016-2028)

11.4.3.  Market Revenue and Forecast, by End User (2016-2028)

11.4.4.  Market Revenue and Forecast, By Route of Administration (2016-2028)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, By Type (2016-2028)

11.4.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.4.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.4.5.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, By Type (2016-2028)

11.4.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.4.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.4.6.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, By Type (2016-2028)

11.4.7.2.      Market Revenue and Forecast, by Application (2016-2028)

11.4.7.3.      Market Revenue and Forecast, by End User (2016-2028)

11.4.7.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, By Type (2016-2028)

11.4.8.2.      Market Revenue and Forecast, by Application (2016-2028)

11.4.8.3.      Market Revenue and Forecast, by End User (2016-2028)

11.4.8.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, By Type (2016-2028)

11.5.2.  Market Revenue and Forecast, by Application (2016-2028)

11.5.3.  Market Revenue and Forecast, by End User (2016-2028)

11.5.4.  Market Revenue and Forecast, By Route of Administration (2016-2028)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, By Type (2016-2028)

11.5.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.5.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.5.5.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, By Type (2016-2028)

11.5.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.5.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.5.6.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

Chapter 12.  Company Profiles

12.1.              GlaxoSmithKline plc

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Pfizer, Inc.

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Baxter

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Leo Pharma A/S

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Sanofi

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Dr. Reddy’s Laboratories Ltd.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Aspen Holdings

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              B. Braun Medical Inc.

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Fresenius SE & Co. KGaA

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Teva Pharmaceutical Industries Ltd.

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Report Details

  • Report Code:35901
  • Category:Healthcare
  • No. of Pages:200
  • Format:PDF/PPT/Excel
  • Published:November 2020
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers